Phocas Financial Corp. Abbott Laboratories Transaction History

Phocas Financial Corp.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 13, 2023	SELL	$96.86 - $114.01 $23,246 - $27,362	-240 Reduced 6.76%	3,310 $335,000
Q4 2022 Jan 10, 2023	SELL	$95.06 - $111.52 $24,715 - $28,995	-260 Reduced 6.82%	3,550 $0
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $400,050 - $435,940	3,810 New	3,810 $417,000
Q2 2019 Aug 16, 2019	SELL	$72.88 - $85.0 $317,756 - $370,600	-4,360 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$53.68 - $57.47 $234,044 - $250,569	4,360	4,360 $0

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

Stay updated on Phocas Financial Corp. with notifications on news.